PRHSX quote
25.19up +0.18 +0.72%
Previous Close25.01CategoryHealth
Net Assets1.93 BilDividend Yield0.00%
Morningstar ratings:Minimum Initial Purchase2,500
RiskAbove Average1 Year ReturnNA
RatingRating: 4 out of 53 Year ReturnNA
ReturnHigh5 Year ReturnNA
Cumulative growth of a $10,000 investment
10k growth chart
20042005200620072008YTD
Growth15.85%31.52%44.12%71.13%21.89%51.75%
Value$11,585$13,152$14,412$17,113$12,189$15,175
Last NAV update 11/24/2009 8:00 PM ET   Financial data in U.S. dollars

Your latest quotes:  PRHSX, DLA, VPACX, BOS, $AU:AOI, CHRW

Overview
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. While it can invest in companies of any size, the fund invests the majority of assets in large- and mid-capitalization companies.
advertisement
More information for PRHSX
Fees and expenses
Front load0.00%
Deferred load0.00%
Expense Ratio0.86%
Top holdings for PRHSX
Company Name% Net Assets
Gilead Sciences, Inc.5.55%
Alexion Pharmaceuticals, Inc.3.79%
Baxter International Inc.3.26%
Medco Health Solutions, Inc.2.72%
Roche Holding AG2.52%
More top holdings for PRHSX
Additional Fund Information
Inception date12/29/1995
ManagerJason Nogueira
Manager start date05/01/2007
advertisement
Market update 4:02am ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news
advertisement


Page generated 7:02 AM Eastern Time